Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2010	The Swedish Council on Health Technology Assessment (SBU)	[Dietary treatment of diabetes]
2000	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Dietary guidance in the primary health care sector (co-funded by DIHTA)]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dielectric radiofrequency for the treatment of primary hyperhidrosis and bromhidrosis]
2022	Institute for Clinical Effectiveness and Health Policy (IECS)	[Diamine oxidase activity test for histamine intolerance]
2006	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Dialysis in chronic renal failure - a health technology assessment]
2021	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Diagnostics and treatment of provoked vestibulodynia]
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Diagnostic value of novel biomarkers in patients with chest pain of suspected cardiac origin]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Diagnostic value of an innovative non-invasive diagnostic to determine the grade of atherosclerosis before sternotomy in patients scheduled for cardiac surgery]
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[Diagnostic usefulness of brain FDG-PET for Alzheimer's dementia]
2019	National Committee for Technology Incorporation (CONITEC)	[Diagnostic tests for thrombophilia in pregnancy]
2002	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Diagnostic radiology using transportable equipment]
2008	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Diagnostic performance of techniques used for HER-2 testing in breast cancer]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Diagnostic performance of digital mammography in breast cancer screening]
2008	Andalusian Health Technology Assessment Area (AETSA)	[Diagnostic performance of clinical prediction models for pulmonary embolism]
2014	The Swedish Council on Health Technology Assessment (SBU)	[Diagnostic imaging in the staging of prostate cancer]
2014	The Swedish Council on Health Technology Assessment (SBU)	[Diagnostic imaging in suspected prostate cancer]
2008	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Diagnostic evaluation and treatment of dementia – a health technology assessment]
2005	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Diagnostic effectiveness, security and clinical usefulness of capsule endoscopy in the diagnosis of small bowel disorders]
2018	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Diagnostic effectiveness and safety of elastography in liver fibrosis]
2009	The Regional Health Technology Assessment Centre (HTA-centrum)	[Diagnostic colon evaluation in patients with suspected colorectal neoplasia or at high risk of colorectal neoplasia - a comparison of double contrast barium enema (DCBE), CT colonography and colonoscopy]
2000	Basque Office for Health Technology Assessment (OSTEBA)	[Diagnostic and therapeutic approach to non complex duodenal ulcer]
2024	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Diagnostic accuracy of impulse oscillometry (IOS) compared to spirometry]
2025	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Diagnostic accuracy of ex vivo confocal microscopy during Mohs surgery for basal cell carcinomas]
2012	National Evidence-based Healthcare Collaborating Agency (NECA)	[Diagnostic accuracy of anti-CCP antibody test in rheumatoid arthritis: systematic review]
2004	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Diagnostic accuracy and clinical usefulness of Positron Emission Tomography (PET) in breast and ovarian cancer recurrence]
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Diagnosis of gestational diabetes mellitus: evaluation of the new IADPSG criteria]
2018	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Diagnosis and treatments for epilepsy – a systematic review]
2006	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Diagnosis and treatment of obstructive sleep apnoea - a health technology assessment]
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Diagnosis and treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in people with Multiple Sclerosis (MS)]
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Diagnosis and treatment of chronic cerebrospinal venous insufficiency (CCSVI) for people with multiple sclerosis]
2013	The Swedish Council on Health Technology Assessment (SBU)	[Diagnosis and treatment of ADHD and ASDs (autism spectrum disorders)]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Diagnosis and staging of lung cancer by endoscopic ultrasound guided fine needle aspiration (EUS-FNA)]
2012	Basque Office for Health Technology Assessment (OSTEBA)	[Diagnosis and consumption of drugs for Alzheimer's disease in the Basque country]
2011	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Diabetic foot ulcers - a health technology assessment]
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Developmental vision disorders: do children and adolescents benefit from active vision training?]
2017	Canary Health Service	[Development of shared decision support tools derived from clinical practice guideline recommendations]
2020	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Development of scientific concepts for the generation of routine practice data and their analysis for the benefit assessment of drugs according to §35a Social Code Book V - rapid report]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Development of quality indicators for laser treatment for benign prostatic hyperplasia. Expert consensus]
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Development of organizational interventions to improve compliance with guidelines on depression and anxiety in primary care]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Development of indicators to assess prevention programs for colorectal cancer in high risk populations]
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Development of evidence-based clinical imaging guidelines : to supply the evidence for appropriateness of diagnostic imaging studies and radiation exposure levels of patients]
2010	National Evidence-based Healthcare Collaborating Agency (NECA)	[Development of empirical treatment guidelines in febrile neutropenic patients on the basis of the Korean data]
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Development of decision-aid: HPV-patient information]
2009	Andalusian Health Technology Assessment Area (AETSA)	[Development of criteria, complexity indicators and management strategies on frailty]
2014	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Development of composite indicators to measure the quality of prevention and chronic management activities for gynecological cancer screening in primary care]
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Development of appropriateness criteria for transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Development of a shared knowledge system for network assessment of technological innovation in medicine]
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Development of a scientific concept for the generation of routine practice data and their analysis for benefit assessments according to §35a Social Code Book (SGB) V in the event of market access for several drugs of one drug class]
2006	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Development of a prognosis model to identify effects of threshold values on health care]
2015	National Evidence-based Healthcare Collaborating Agency (NECA)	[Development of a preference-based instrument: Asian Comparative Study]
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Development of a model for predicting emergency hospital admission and readmission in Catalonia]
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Development of a decision aid for carotid revascularization surgery for carotid stenosis]
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Development of a decision aid for aortic aneurysm interventions]
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Development of a basic set of expert consensus-based quality indicators for the care delivered to stroke patients]
2015	Institut national d'excellence en sante et en services sociaux (INESSS)	[Development framework for social services practice guidelines]
2010	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Development and validation of methods for quality assessment of health technologies assessments reports : assessment of ethical issues in health technologies assessment]
2008	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Development and validation of methods for quality assessment of health technologies assessment reports]
2012	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Development and validation of methods for quality assessment of health technologies assessment reports. Evaluation of the quality of qualitative studies]
2008	Basque Office for Health Technology Assessment (OSTEBA)	[Development and evaluation of tools designed in order to ensure patient safety for possible incorporation into the management of healthcare processes]
2010	Canary Health Service	[Development and evaluation of a decision support tool for benign prostatic hyperplasia patients]
2012	The Netherlands Organisation for Health Research and Development (ZonMw)	[Development and application of clinical prediction models in the presence of multilevel data]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Deucravacitinib (plaque psoriasis) – Benefit assessment according to §35a Social Code Book V]
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Determining optimal intervals for screening and surveillance: using individualized risk estimates to increase cost-effectiveness]
2019	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Determination of the SHI target population for the therapeutic indication type 2 diabetes mellitus using SHI routine data]
2014	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Determination of antigen expression levels of uPA and PAI-1 in primary breast cancer with intermediate recurrence risk after R0 primary surgery]
2023	Canary Health Service	[Determination by chemiluminescence of autoantibodies to domain 1 of beta 2 glycoprotein I in patients with antiphospholipid syndrome]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Detection of sperm DNA fragmentation (TUNEL, SCSA, SCD, COMET) and use of annexin columns (MACS) in assisted reproduction treatments]
2024	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Detection of IDH1 mutations in cholangiocarcinoma patients]
2010	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Detection of high risk human papillomavirus E6 and E7 oncogenes for cervical cancer screening]
2014	Haute Autorite de sante (HAS)	[Detection of enterovirus genome in cerebrospinal fluid by gene amplification in meningitis patients]
2015	Institut national d'excellence en sante et en services sociaux (INESSS)	[Detection and diagnosis of Alzheimer's disease and other neurocognitive disorders]
2008	The Netherlands Organisation for Health Research and Development (ZonMw)	[Detecting COPD in persons over 50 years with persistent cough in general practice: comparison of cost-effectiveness of diagnostic strategies]
2012	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[DETECTA-T]
2011	Health Intervention and Technology Assessment Program (HITAP)	[Designing a decision frame for making health resource allocation decisions: a case study in Thailand]
2013	Basque Office for Health Technology Assessment (OSTEBA)	[Design of an interaction protocol between Primary Care and Hospitals to improve early detection and monitoring of patients with multiple sclerosis]
2016	Basque Office for Health Technology Assessment (OSTEBA)	[Design and validation of a screening tool for evaluating the health impact of regional policies]
2010	Basque Office for Health Technology Assessment (OSTEBA)	[Design and implementation plan of telemedicine in specific clinical areas: telemonitoring and teledermatology. Assessment of initial results and costs]
2021	Center for Drug Evaluation (CDE)	[Descriptive study and comparative effectiveness of listed medications for osteoporosis on new osteoporotic fracture event in osteoporosis patients by using National Health Insurance claim database]
2012	Institut national d'excellence en sante et en services sociaux (INESSS)	[Description of the use of Proton Pump Inhibitors (PPIs) in adults covered by the public prescription drug insurance plan]
2005	Basque Office for Health Technology Assessment (OSTEBA)	[Description of the elaboration of a clinical practice guidelines for asthma in the autonomous community of the Basque country by means of a mixed method of adaptation-development-actualization]
2021	Norwegian Institute of Public Health (NIPH)	[Description and quality assessment of guidelines for tonsillectomy in patients with recurrent tonsillitis: mapping review]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal endothelial dysfunction]
2006	The Netherlands Organisation for Health Research and Development (ZonMw)	[Depression in chronically ill elderly]
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Depression in children and adolescents: does psychotherapy lead to better results compared to other therapies?]
2009	Haute Autorite de sante (HAS)	[Dental prostheses with ceramic and/or milled cores (full assessment)]
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Dental indications for standardised procedures of instrumental functional analysis under consideration of health economic aspects]
2010	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Dental indications for standardised procedures of instrumental functional analysis under consideration of health economic aspects]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Denosumab versus bisphosphonates for the treatment of osteoporosis in post-menopausal women]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Denosumab for the treatment of solid tumor bone metástasis]
2008	Andalusian Health Technology Assessment Area (AETSA)	[Denaturing high performance liquid chromatography (DHPLC). Use and utility in massive genotyping]
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Delgocitinib (moderate to severe chronic hand eczema) – benefit assessment according to §35a Social Code Book V]
2025	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Delgocitinib (moderate to severe chronic hand eczema) – addendum to Project A24-107]
2011	Committee for New Health Technology Assessment (CNHTA)	[Deletion of 18q choromosome in colorectal cancer (LOH, loss of heterozygosity)]
2022	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Delamanid (pulmonary multi-drug resistant tuberculosis, body weight >= 10 kg) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Defibrillators in public places]
2017	Institute for Clinical Effectiveness and Health Policy (IECS)	[Deferred parathyroid autograft with cryopreserved tissue for the surgical management of hyperparathyroidism]
2005	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[Deep brain stimulation using electrodes in the treatment of Parkinson's Disease]
2010	Andalusian Health Technology Assessment Area (AETSA)	[Deep brain stimulation in the treatment of depressive and obsessive-complusive disorders]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Deep brain stimulation in patients with treatment-resistant depressive disorder, obsessive compulsive disorder and Tourette syndrome]
2013	Canary Health Service	[Deep brain stimulation in neurological and psychiatric disorders]